| abstract |
Subject of the invention is a molecule of general structural formula N0. I, where x: 1 or 2 valent metal ion is appropriate from a therapeutic point of view, the value n: 1 or 2, or the metabolite of molecule I, for use in the treatment or prevention of embryonic retardation or the uncoordinated development of multiple embryos or, for the manufacture of a medicament for the treatment or prevention of embryonic retardation or the uncoordinated development of multiple embryos. |